ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,318,000 | +46.0% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $903,000 | -1.0% | 180,582 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $912,000 | -18.6% | 180,582 | 0.0% | 0.01% | -11.1% |
| Q3 2017 | $1,120,000 | +72.3% | 180,582 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $650,000 | +10.7% | 180,582 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $587,000 | +32.8% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $442,000 | -28.8% | 180,582 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $621,000 | -1.1% | 180,582 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $628,000 | -15.8% | 180,582 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $746,000 | -7.2% | 180,582 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $804,000 | -26.9% | 180,582 | 0.0% | 0.01% | -30.0% |
| Q3 2015 | $1,100,000 | – | 180,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |